Advances in treating bacterial vaginosis: recognizing sexual transmission and pipeline of therapies
Several advances in managing recurrent BV have shown promise in improving care of this condition. They represent a shift toward microbiome-informed, durable, and woman-controlled therapies. Strategies combining these along with continued development of promising novel approaches to treatment will be needed to optimize care of patients and reduce global BV burden.
Authors
- Joseph A. Duncan (ORCID: https://orcid.org/0000-0002-4438-2018)
- Indriati Hood-Pishchany
- Eun Sol Kim (ORCID: https://orcid.org/0000-0001-8801-421X)
- Andreea Waltmann (ORCID: https://orcid.org/0000-0001-9219-6570)
Institutions
- University of North Carolina at Chapel Hill (US)
- Segeberger Kliniken (DE)
- UNC Lineberger Comprehensive Cancer Center
Publication Details
- Journal
- Current Opinion in Infectious Diseases
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1097/qco.0000000000001172
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00